Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for Contineum Therapeutics (CTNM) over the last 2 years, with Dec 2024 value amounting to $3,000.

  • Contineum Therapeutics' Other Non-Current Assets rose 8766.67% to $266,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $266,000, marking a year-over-year increase of 8766.67%. This contributed to the annual value of $3,000 for FY2024, which is 99.77% down from last year.
  • According to the latest figures from FY2024, Contineum Therapeutics' Other Non-Current Assets is $3,000, which was down 99.77% from $1.3 million recorded in FY2023.
  • In the past 5 years, Contineum Therapeutics' Other Non-Current Assets registered a high of $1.3 million during FY2023, and its lowest value of $3,000 during FY2024.
  • Moreover, its 2-year median value for Other Non-Current Assets was $643,000 (2023), whereas its average is $643,000.
  • Data for Contineum Therapeutics' Other Non-Current Assets shows a maximum YoY slumped of 99.77% (in 2024) over the last 5 years.
  • Over the past 2 years, Contineum Therapeutics' Other Non-Current Assets (Yearly) stood at $1.3 million in 2023, then plummeted by 99.77% to $3,000 in 2024.